184 related articles for article (PubMed ID: 28916653)
21. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer.
Dong Q; Fu L; Zhao Y; Du Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Apr; 8(17):27800-27811. PubMed ID: 28468127
[TBL] [Abstract][Full Text] [Related]
22. MiR-361 targets Yes-associated protein (YAP) mRNA to suppress cell proliferation in lung cancer.
Zhang S; Liu Z; Wu L; Wang Y
Biochem Biophys Res Commun; 2017 Oct; 492(3):468-473. PubMed ID: 28837805
[TBL] [Abstract][Full Text] [Related]
23. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
[TBL] [Abstract][Full Text] [Related]
24. Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress.
Wang Y; Li J; Gao Y; Luo Y; Luo H; Wang L; Yi Y; Yuan Z; Jim Xiao ZX
Redox Biol; 2019 Sep; 26():101233. PubMed ID: 31212215
[TBL] [Abstract][Full Text] [Related]
25. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
[TBL] [Abstract][Full Text] [Related]
26. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
[TBL] [Abstract][Full Text] [Related]
27. RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway.
Dubois F; Keller M; Calvayrac O; Soncin F; Hoa L; Hergovich A; Parrini MC; Mazières J; Vaisse-Lesteven M; Camonis J; Levallet G; Zalcman G
Cancer Res; 2016 Mar; 76(6):1627-40. PubMed ID: 26759237
[TBL] [Abstract][Full Text] [Related]
28. YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity.
Sugihara T; Werneburg NW; Hernandez MC; Yang L; Kabashima A; Hirsova P; Yohanathan L; Sosa C; Truty MJ; Vasmatzis G; Gores GJ; Smoot RL
Mol Cancer Res; 2018 Oct; 16(10):1556-1567. PubMed ID: 29903769
[TBL] [Abstract][Full Text] [Related]
29. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
[TBL] [Abstract][Full Text] [Related]
30. Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity.
Yang G; Li Z; Chen L
Tissue Cell; 2020 Aug; 65():101346. PubMed ID: 32746992
[TBL] [Abstract][Full Text] [Related]
31. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.
Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z
Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283
[TBL] [Abstract][Full Text] [Related]
32. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKɛ-mediated phosphorylation.
Wang S; Xie F; Chu F; Zhang Z; Yang B; Dai T; Gao L; Wang L; Ling L; Jia J; van Dam H; Jin J; Zhang L; Zhou F
Nat Immunol; 2017 Jul; 18(7):733-743. PubMed ID: 28481329
[TBL] [Abstract][Full Text] [Related]
33. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
Yang F; Li L; Zhang J; Zhang J; Yang L
Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
[TBL] [Abstract][Full Text] [Related]
34. The curcumin analogue WZ35 affects glycolysis inhibition of gastric cancer cells through ROS-YAP-JNK pathway.
Chen T; Zhao L; Chen S; Zheng B; Chen H; Zeng T; Sun H; Zhong S; Wu W; Lin X; Wang L
Food Chem Toxicol; 2020 Mar; 137():111131. PubMed ID: 31958483
[TBL] [Abstract][Full Text] [Related]
35. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
[TBL] [Abstract][Full Text] [Related]
36. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
37. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop.
Lapi E; Di Agostino S; Donzelli S; Gal H; Domany E; Rechavi G; Pandolfi PP; Givol D; Strano S; Lu X; Blandino G
Mol Cell; 2008 Dec; 32(6):803-14. PubMed ID: 19111660
[TBL] [Abstract][Full Text] [Related]
38. YAP drives cutaneous squamous cell carcinoma formation and progression.
Vincent-Mistiaen Z; Elbediwy A; Vanyai H; Cotton J; Stamp G; Nye E; Spencer-Dene B; Thomas GJ; Mao J; Thompson B
Elife; 2018 Sep; 7():. PubMed ID: 30231971
[TBL] [Abstract][Full Text] [Related]
39. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
[TBL] [Abstract][Full Text] [Related]
40. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
